Pharmacokinetics of teicoplanin in man after intravenous administration

Gian Luigi Traina, Maurizio Bonati

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The pharmacokinetics of teicoplanin, a new glycopeptide antibiotic active against gram-positive aerobic and anaerobic bacteria, was studied in adult male volunteers given 2- and 3- mg/ kg doses by a constant-rate 0.5-hr infusion. Serum and urine samples were collected up to 96 hr. Mean peak serum levels after the two doses were 15.7 and 22.4 μg/ml. Postinfusion serum teicoplanin levels showed triexponential decay. A three-compartment body model gave close values for pharmacokinetic parameters after the two doses. The mean half-life of the λ1 phase was 20.3 min, that of the λ2 phase was 2.9 hr, and the half-life of the estimated λ3 phase was 40.5 hr, in good agreement with that of the λZ phase (45.9 hr) calculated from the last urine data. The mean volume of distribution of the central compartment was 0.09 liter/kg and the steady-state volume of distribution using noncompartmental analysis was 0.84 liter/kg. Total clearance averaged 16.05 ml/hr/kg, with renal clearance arbout half this (9.51 ml/hr/kg), calculated by two different methods. The average total recovery of active teicoplanin in urine over 4 days was 52%, suggesting that both renal and nonrenal mechanisms are involved in elimination of the drug. The concentrations of teicoplanin in serum and urine exceeded the MIC (ranging from 0.02 to 2 μg/ml) on many pathogenic organisms for at least 1 day after administration.

Original languageEnglish
Pages (from-to)119-128
Number of pages10
JournalJournal of Pharmacokinetics and Biopharmaceutics
Volume12
Issue number2
DOIs
Publication statusPublished - Apr 1984

Fingerprint

Teicoplanin
Intravenous Administration
Pharmacokinetics
Urine
Serum
Half-Life
Kidney
Aerobic Bacteria
Anaerobic Bacteria
Glycopeptides
Gram-Positive Bacteria
Volunteers
Anti-Bacterial Agents
Pharmaceutical Preparations

Keywords

  • noncompartmental analysis
  • pharmacokinetics
  • teicoplanin
  • three-compartment model

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Pharmacokinetics of teicoplanin in man after intravenous administration. / Traina, Gian Luigi; Bonati, Maurizio.

In: Journal of Pharmacokinetics and Biopharmaceutics, Vol. 12, No. 2, 04.1984, p. 119-128.

Research output: Contribution to journalArticle

@article{a476ab71c25640ccbd9488861ad42502,
title = "Pharmacokinetics of teicoplanin in man after intravenous administration",
abstract = "The pharmacokinetics of teicoplanin, a new glycopeptide antibiotic active against gram-positive aerobic and anaerobic bacteria, was studied in adult male volunteers given 2- and 3- mg/ kg doses by a constant-rate 0.5-hr infusion. Serum and urine samples were collected up to 96 hr. Mean peak serum levels after the two doses were 15.7 and 22.4 μg/ml. Postinfusion serum teicoplanin levels showed triexponential decay. A three-compartment body model gave close values for pharmacokinetic parameters after the two doses. The mean half-life of the λ1 phase was 20.3 min, that of the λ2 phase was 2.9 hr, and the half-life of the estimated λ3 phase was 40.5 hr, in good agreement with that of the λZ phase (45.9 hr) calculated from the last urine data. The mean volume of distribution of the central compartment was 0.09 liter/kg and the steady-state volume of distribution using noncompartmental analysis was 0.84 liter/kg. Total clearance averaged 16.05 ml/hr/kg, with renal clearance arbout half this (9.51 ml/hr/kg), calculated by two different methods. The average total recovery of active teicoplanin in urine over 4 days was 52{\%}, suggesting that both renal and nonrenal mechanisms are involved in elimination of the drug. The concentrations of teicoplanin in serum and urine exceeded the MIC (ranging from 0.02 to 2 μg/ml) on many pathogenic organisms for at least 1 day after administration.",
keywords = "noncompartmental analysis, pharmacokinetics, teicoplanin, three-compartment model",
author = "Traina, {Gian Luigi} and Maurizio Bonati",
year = "1984",
month = "4",
doi = "10.1007/BF01059273",
language = "English",
volume = "12",
pages = "119--128",
journal = "Journal of Pharmacokinetics and Pharmacodynamics",
issn = "1567-567X",
publisher = "Kluwer/Plenum Publishers",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of teicoplanin in man after intravenous administration

AU - Traina, Gian Luigi

AU - Bonati, Maurizio

PY - 1984/4

Y1 - 1984/4

N2 - The pharmacokinetics of teicoplanin, a new glycopeptide antibiotic active against gram-positive aerobic and anaerobic bacteria, was studied in adult male volunteers given 2- and 3- mg/ kg doses by a constant-rate 0.5-hr infusion. Serum and urine samples were collected up to 96 hr. Mean peak serum levels after the two doses were 15.7 and 22.4 μg/ml. Postinfusion serum teicoplanin levels showed triexponential decay. A three-compartment body model gave close values for pharmacokinetic parameters after the two doses. The mean half-life of the λ1 phase was 20.3 min, that of the λ2 phase was 2.9 hr, and the half-life of the estimated λ3 phase was 40.5 hr, in good agreement with that of the λZ phase (45.9 hr) calculated from the last urine data. The mean volume of distribution of the central compartment was 0.09 liter/kg and the steady-state volume of distribution using noncompartmental analysis was 0.84 liter/kg. Total clearance averaged 16.05 ml/hr/kg, with renal clearance arbout half this (9.51 ml/hr/kg), calculated by two different methods. The average total recovery of active teicoplanin in urine over 4 days was 52%, suggesting that both renal and nonrenal mechanisms are involved in elimination of the drug. The concentrations of teicoplanin in serum and urine exceeded the MIC (ranging from 0.02 to 2 μg/ml) on many pathogenic organisms for at least 1 day after administration.

AB - The pharmacokinetics of teicoplanin, a new glycopeptide antibiotic active against gram-positive aerobic and anaerobic bacteria, was studied in adult male volunteers given 2- and 3- mg/ kg doses by a constant-rate 0.5-hr infusion. Serum and urine samples were collected up to 96 hr. Mean peak serum levels after the two doses were 15.7 and 22.4 μg/ml. Postinfusion serum teicoplanin levels showed triexponential decay. A three-compartment body model gave close values for pharmacokinetic parameters after the two doses. The mean half-life of the λ1 phase was 20.3 min, that of the λ2 phase was 2.9 hr, and the half-life of the estimated λ3 phase was 40.5 hr, in good agreement with that of the λZ phase (45.9 hr) calculated from the last urine data. The mean volume of distribution of the central compartment was 0.09 liter/kg and the steady-state volume of distribution using noncompartmental analysis was 0.84 liter/kg. Total clearance averaged 16.05 ml/hr/kg, with renal clearance arbout half this (9.51 ml/hr/kg), calculated by two different methods. The average total recovery of active teicoplanin in urine over 4 days was 52%, suggesting that both renal and nonrenal mechanisms are involved in elimination of the drug. The concentrations of teicoplanin in serum and urine exceeded the MIC (ranging from 0.02 to 2 μg/ml) on many pathogenic organisms for at least 1 day after administration.

KW - noncompartmental analysis

KW - pharmacokinetics

KW - teicoplanin

KW - three-compartment model

UR - http://www.scopus.com/inward/record.url?scp=0021171566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021171566&partnerID=8YFLogxK

U2 - 10.1007/BF01059273

DO - 10.1007/BF01059273

M3 - Article

VL - 12

SP - 119

EP - 128

JO - Journal of Pharmacokinetics and Pharmacodynamics

JF - Journal of Pharmacokinetics and Pharmacodynamics

SN - 1567-567X

IS - 2

ER -